Author:
Kiboi D.M.,Irungu B.N.,Langat B.,Wittlin S.,Brun R.,Chollet J.,Abiodun O.,Nganga J.K.,Nyambati V.C.S.,Rukunga G.M.,Bell A.,Nzila A.
Subject
Immunology,General Medicine,Parasitology,Infectious Diseases
Reference65 articles.
1. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10;Afonso;Antimicrobial Agents Chemotherapy,2006
2. Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects;Ahmed;Journal of Clinical Pharmacology,2008
3. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand;Ashley;Journal of Infectious Diseases,2004
4. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria;Ashley;Clinical Infectious Diseases,2005
5. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon;Basco;Antimicrobial Agents Chemotherapy,2003
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献